Arete-Zoe

Arete-Zoe Medical device and drug safety consulting ARETE-ZOE, provides full spectrum organizational and operational risk management consultancy.

ARETE-ZOE, as a consultancy, provides solutions to complex problems in the high stakes and high consequence environment of Global Pharmaceuticals, including clinical research, healthcare informatics, and public health. We blend established, Pharma sector methodologies, innovation, and adaptations/transfers from other sectors to identify and resolve consequential practices that pose risk and often

result in avoidable patient casualty. However, we are specifically, not a patient advocacy group but believe in optimizing organizational effectiveness and that smart business is agile, competitive and profitable, while intrinsically safe, secure, and resilient. We work within a global context because transnational interests influence national circumstances and choices at point of prescription. The published materials provide a glimpse of one aspect of our services to demonstrate both knowledge and going participation within the Pharmaceutical Industry. Our analysis and consultancy includes all channels of misuse, diversion, counterfeiting and illicit exploitation of pharmaceuticals, medical devices, and precursor chemicals. Our advisement is to manufactures, jurisdictional entities, insurers, legislators, litigators, patients, and health care providers. This scope also frequently segues into the nexus of crime and terrorism as significant influencers that undermine sector integrity differentiated from other criminal activity. Obviously, vulnerability assessment, information collection management and intelligence production supporting decision-making for risk reduction and interventions are routinely with the scope of our services as well as design and implementation of operational control measures.

03/21/2025

Join us for another session of the Let's Talk Risk! conversation. My guest is Veronika Valdova, who will share automation tools for clinical evaluation. Recordings of our past discussions are available here https://naveenagarwalphd.substack.com/podcast

The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up stud...
01/21/2025

The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study

Authors: Veronika Valdová, Vladimíra Štěpánová, Lenka Lapčíková

https://www.frontiersin.org/journals/drug-safety-and-regulation/articles/10.3389/fdsfr.2024.1402684/full

Introduction: Chronic wounds are a significant public health challenge, representing a considerable burden on the healthcare system. There are numerous gaps in knowledge in the treatment of chronic wounds. First, it is difficult to follow patients through different types of care. Wounds in polymorbid, elderly patients often remain unhealed due to the patient succumbing to their primary disease. No reliable data exist regarding the time to wound closure, type of interventions, the use of antibiotics, the nature and rate of complications, or the causes of treatment failures.

Methods: This Post-Market Clinical Follow-Up (PMCF) study is a prospective, multicentric, observational, descriptive, qualitative survey among healthcare professionals that involves 237 patients with acute and chronic wounds treated with superoxide-based wound irrigation solution DebriEcaSan Alfa in real-world settings over 12 weeks, both outpatient and inpatient. The study aimed to collect additional clinical data to confirm the safety, performance, and clinical benefit of DebriEcaSan Alfa.

Results: The Manufacturer collected 237 survey forms from 81 healthcare facilities, nursing homes, and outpatient clinics in the Czech Republic. The most common diagnoses were venous leg ulcer, pressure ulcer, diabetic foot ulcer, and traumatic wound. The most common comorbidities and risk factors were obesity, diabetes mellitus, and peripheral artery disease. Significant improvement was observed in all parameters, including pain, malodor, affected tissues, reduction in wound size, and granulation and epithelization. A marked reduction in size was observed in all wound size categories. 19 (8%) patients healed by end of week 6; and 66 (28%) healed by week 9. 130 (55%) patients were considered healed by week 12.

Discussion: The current clinical practice guidelines refrain from recommending any of the available irrigation solutions and wound dressings due to low-quality evidence. Superoxidized solutions have excellent biocompatibility and are non-cytotoxic, non-sensitizing, not irritating, non-genotoxic, and have broad-spectrum antimicrobial properties. There is no objective baseline to compare the results to, as typical healing times in a comparable population are not accessible. No single standard of care exists in the treatment of chronic wounds, and significant variability in practices exists across the health system.

Introduction: Chronic wounds are a significant public health challenge, representing a considerable burden on the healthcare system. There are numerous gaps in knowledge in the treatment of chronic wounds. First, it is difficult to follow patients through different types of care. Wounds in polymorbi...

🎬 Upcoming webinar – Registrations now open! Join us for Part 2: Expert Guidance on Vigilance Medical Devices Webinar Se...
05/07/2024

🎬 Upcoming webinar – Registrations now open! Join us for Part 2: Expert Guidance on Vigilance Medical Devices Webinar Series.

Webinar topic: "Navigating post-marketing safety surveillance of medical devices and drug-device combination products, E.U. and USA."

In this session, industry expert Veronika Valdova will guide you through the reporting essentials and obligations associated with the post-marketing safety surveillance of these products in both the E.U. and U.S. markets.

Save the date: Wednesday, May 29th. Choose a session:
🕚 Session 1: 6am ET | 12pm CET
🕚 Session 2: 10am ET | 4pm CET
🕚 Session 3: 2pm ET | 8pm CET

👉 Register now: https://lnkd.in/ddRFMsaa

🔍 Webinar Agenda:
• Introduction to drug-device and combination products
• Types of Drug-Device Combinations (DDCs) in Europe and the U.S.
• Reporting essentials and obligations
• Essential procedures to cover
• Comparison of reporting requirements in the E.U. vs the U.S.
• Current trends and challenges
• Best practices and key takeaways

Don’t miss the opportunity to gain valuable insights into the complexities of safety surveillance and ensure compliance with international standards.

Catch up on Part 1 of the webinar series here: https://lnkd.in/dnT7rtMF

By registering, you will automatically receive a link to the webinar recording after the event.

If you have any questions, please write to us at [email protected]. See you soon!

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

05/06/2024

Title: AI and Smart Tools for Enhanced Surveillance

Zoom registration: https://zoom.us/webinar/register/WN_OYKD8YRaRvyrZK6-2NTksg #/registration

Linkedin Event: https://www.linkedin.com/events/aiandsmarttoolsforenhancedsurve7193244683362299907/

Description: Join us for a special edition webinar session where we bring together three expert speakers to explore the latest advancements in AI automations and smart tools for surveillance. In this special session, our panelists will dive deep into practical examples, demonstrating how these technologies will revolutionize the industry.

Discover how AI-driven solutions can amplify your surveillance capabilities, optimising efficiency, uncovering pertinent information, and gaining a competitive advantage, among other benefits.

Be sure to tune in for an exclusive look at the new Hoodin platform, showcasing how AI and smart tools can elevate your vigilance strategies. Don't miss this opportunity to upskill and stay ahead with cutting-edge surveillance.

🎙️ Speakers: Tobias Winstel, Veronika Valdova & Martin King

🗓️ When: May 16, 4pm CET / 11am EST
📍 Where: Zoom Webinar
⏱️ Duration: 30-45 minutes

https://www.hoodin.com/post/raqa-deep-dives-with-veronika-valdova
05/03/2024

https://www.hoodin.com/post/raqa-deep-dives-with-veronika-valdova

Welcome to the Hoodin RAQA Deep Dive Sessions blog post! In this edition, we'll explore insights from our recent session with Veronika Valdova, an expert in Global Regulatory Affairs.This post serves as a valuable resource for navigating regulatory challenges focused on situations where a product st...

04/24/2024

https://zoom.us/webinar/register/WN_PzIv7IBOTr6pl67ejWfIJg #/registration

Drug in the US, device in the EU: Navigating the Treacherous Waters of Combined Registrations
Date & TimeMay 2, 2024 04:00 PM in
DescriptionCertain products can be classified as a drug in one country and as a device in another simultaneously. Examples of such products include regional citrate anticoagulation for hemodialysis, which is categorized as a class IIb device in Europe but as a drug in the US. Simethicone, classified as a Rule 21, class IIa device in Europe, is considered a drug in the US. Similarly, litramine, Na/Mg alginate, xyloglucan, diosmectite, or activated charcoal are identified as devices in Europe but can be regarded as drugs or nutritional supplements in the US. The determining factor is the product’s principal mode of action. Consequently, the same product may be subject to different regulatory frameworks in each jurisdiction, posing significant challenges for post-market surveillance in terms of both content and format.

https://www.youtube.com/watch?v=d0rydSpLAfU
04/18/2024

https://www.youtube.com/watch?v=d0rydSpLAfU

FDA Commissioner Robert Califf testified in front of the House Appropriations Committee on Thursday. Fuel your success with Forbes. Gain unlimited access to ...

🎬 Vigilance Medical Device Webinar: Registration Now Open! Join us on April 17 for Part 1 of Qinecsa Solutions' webinar ...
03/20/2024

🎬 Vigilance Medical Device Webinar: Registration Now Open!

Join us on April 17 for Part 1 of Qinecsa Solutions' webinar series, “Vigilance Medical Device Guidance –Mastering Medical Device Regulations (EU) 2017/745.”

During this webinar, you will explore how to seamlessly integrate medical devices into your pharma portfolio with expert guidance from our renowned specialist Veronika Valdova. Gain practical strategies for navigating regulations and establishing robust management processes.

🔍 Key Topics Include:
• Introduction to Medical Device Regulatory Requirements
• Addressing Practical Challenges
• Key Takeaways
• Q&A Session

📅 Save the Date: Choose from three convenient sessions on Wednesday, April 17th:

🕚 Session 1: 6am ET | 11am CET
🕚 Session 2: 10am ET | 3pm CET
🕚 Session 3: 2pm ET | 7pm CET

👉 Register Here: https://lnkd.in/dFTq--Bw

🎯 Ideal for:
• MedTech company leaders in acquisition by pharma
• Pharma company leaders expanding their portfolio to include device products.

Secure your space today and stay ahead in the regulatory landscape.

For any questions about this webinar, please feel free to contact us. See you soon!

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

EU MDR & IVDR Vigilance Expert MasterclassIf you've ever dealt with VIGILANCE, you know how complex and time-consuming i...
02/06/2024

EU MDR & IVDR Vigilance Expert Masterclass
If you've ever dealt with VIGILANCE, you know how complex and time-consuming it can be. In the recording of the Masterclass found below, you may witness Veronika Valdova teaching the challenges regarding vigilance for post-market surveillance, including the submission process and compliance with surveillance and vigilance requirements.

The full recording of the Masterclass is further down on this page.

During the Masterclass, it was highlighted that one of the best things to consider is applying a systematic approach. No matter if you do it manually, semi-manually, or using software such as Hoodin for full automation.

A systematic approach to vigilance for medical devices is vital for maintaining compliance, ensuring patient safety, and driving continuous improvement in the medical device industry. It provides a structured framework for identifying, assessing, and managing risks associated with medical devices, ultimately leading to better outcomes for patients and healthcare providers. See the video at 29:00 for this section.

This is a great chance for you to try out an AI-driven and fully automated tool for surveillance & vigilance.
Feel free to take a look at the tutorial below or sign up for a free 14-day trial of Hoodin here:

EU MDR & IVDR Vigilance Expert Workshop. Monitoring adverse events across products and regions, along with Eudamed delays and country database limitations, can make it even more challenging. Get real insider search tips for Maude, Eudamed, MHRA, BFARM + 10 more country databases. Veronika Valdova as...

Address

PO Box 88255
Steilacoom, WA
98388

Alerts

Be the first to know and let us send you an email when Arete-Zoe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Arete-Zoe:

Share